Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

124 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Donor KIR2DS1 reduces the risk of transplant related mortality in HLA-C2 positive young recipients with hematological malignancies treated by myeloablative conditioning.
Tordai A, Bors A, Kiss KP, Balassa K, Andrikovics H, Batai A, Szilvasi A, Rajczy K, Inotai D, Torbagyi E, Lengyel L, Barta A, Remenyi P, Masszi T. Tordai A, et al. Among authors: kiss kp. PLoS One. 2019 Jun 25;14(6):e0218945. doi: 10.1371/journal.pone.0218945. eCollection 2019. PLoS One. 2019. PMID: 31237928 Free PMC article.
Recipient and donor JAK2 46/1 haplotypes are associated with acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.
Balassa K, Krahling T, Remenyi P, Batai A, Bors A, Kiss KP, Torbagyi E, Gopcsa L, Lengyel L, Barta A, Varga G, Tordai A, Masszi T, Andrikovics H. Balassa K, et al. Among authors: kiss kp. Leuk Lymphoma. 2017 Feb;58(2):391-398. doi: 10.1080/10428194.2016.1198956. Epub 2016 Jul 7. Leuk Lymphoma. 2017. PMID: 27389386
Sex-specific survival difference in association with HLA-DRB1∗04 following allogeneic haematopoietic stem cell transplantation for lymphoid malignancies.
Balassa K, Andrikovics H, Remenyi P, Batai A, Szilvasi A, Bors A, Kiss KP, Rajczy K, Inotai D, Torbagyi E, Lengyel L, Barta A, Gopcsa L, Tordai A, Masszi T. Balassa K, et al. Among authors: kiss kp. Hum Immunol. 2018 Jan;79(1):13-19. doi: 10.1016/j.humimm.2017.10.010. Epub 2017 Oct 31. Hum Immunol. 2018. PMID: 29080718
The potential role of HLA-DRB1*11 in the development and outcome of haematopoietic stem cell transplantation-associated thrombotic microangiopathy.
Balassa K, Andrikovics H, Remenyi P, Batai A, Bors A, Kiss KP, Szilvasi A, Rajczy K, Inotai D, Gopcsa L, Lengyel L, Barta A, Reti M, Tordai A, Masszi T. Balassa K, et al. Among authors: kiss kp. Bone Marrow Transplant. 2015 Oct;50(10):1321-5. doi: 10.1038/bmt.2015.161. Epub 2015 Jul 6. Bone Marrow Transplant. 2015. PMID: 26146809
Co-occurrence of Myeloproliferative Neoplasms and Solid Tumors Is Attributed to a Synergism Between Cytoreductive Therapy and the Common TERT Polymorphism rs2736100.
Krahling T, Balassa K, Kiss KP, Bors A, Batai A, Halm G, Egyed M, Fekete S, Remenyi P, Masszi T, Tordai A, Andrikovics H. Krahling T, et al. Among authors: kiss kp. Cancer Epidemiol Biomarkers Prev. 2016 Jan;25(1):98-104. doi: 10.1158/1055-9965.EPI-15-0805. Epub 2015 Oct 20. Cancer Epidemiol Biomarkers Prev. 2016. PMID: 26487696
HLA genetic diversity in Hungarians and Hungarian Gypsies: complementary differentiation patterns and demographic signals revealed by HLA-A, -B and -DRB1 in Central Europe.
Inotai D, Szilvasi A, Benko S, Boros-Major A, Illes Z, Bors A, Kiss KP, Rajczy K, Gelle-Hossó A, Buhler S, Nunes JM, Sanchez-Mazas A, Tordai A. Inotai D, et al. Among authors: kiss kp. Tissue Antigens. 2015 Aug;86(2):115-21. doi: 10.1111/tan.12600. Epub 2015 Jul 7. Tissue Antigens. 2015. PMID: 26149581
124 results